Human TIM-3 / HAVCR2 Protein, His Tag (MALS verified)
分子別名(Synonym)
HAVCR2,TIM3,TIMD3,FLJ14428,KIM3
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human TIM-3, His Tag (TM3-H5229) is expressed from human 293 cells (HEK293). It contains AA Ser 22 - Arg 200 (Accession # Q8TDQ0-1).
Predicted N-terminus: Ser 22
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 21.8 kDa. The protein migrates as 44-50 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
甲型肝炎病毒細(xì)胞受體2也稱為HAVCR2、FLJ14428、KIM3、TIM3、TIMD3,是TIM家族免疫調(diào)節(jié)分子的成員,具有一個(gè)Ig樣V型結(jié)構(gòu)域和一個(gè)富含Ser/Thr的粘蛋白柄。CD4陽性T輔助淋巴細(xì)胞根據(jù)其細(xì)胞因子分泌模式可分為1型(Th1)和2型(Th2)。Th1細(xì)胞及其相關(guān)細(xì)胞因子參與細(xì)胞介導(dǎo)的對(duì)細(xì)胞內(nèi)病原體的免疫和遲發(fā)型超敏反應(yīng),而Th2細(xì)胞參與控制細(xì)胞外蠕蟲感染和促進(jìn)特應(yīng)性和過敏性疾病。這兩種細(xì)胞也交叉調(diào)節(jié)另一種細(xì)胞的功能。HAVCR2是一種Th1特異性細(xì)胞表面蛋白,調(diào)節(jié)巨噬細(xì)胞活化,增強(qiáng)小鼠實(shí)驗(yàn)性自身免疫性腦脊髓炎的嚴(yán)重程度。HAVCR2調(diào)節(jié)巨噬細(xì)胞活化。抑制T輔助1型淋巴細(xì)胞(Th1)介導(dǎo)的自身和同種異體免疫反應(yīng),促進(jìn)免疫耐受。也可能參與T細(xì)胞歸巢。HAVCR2-galectin-9通路的失調(diào)可能是人類慢性自身免疫性疾病狀態(tài)的基礎(chǔ),如多發(fā)性硬化癥。
關(guān)鍵字: TIM-3;TIM-3蛋白;TIM-3重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。